IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation

Clinical trial NCT05339581 · UNKNOWN

Trial details

NCT number: NCT05339581
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Cancer Liver Transplant; Complications Hepatocellular Carcinoma Portal Vein Thrombosis Radiotherapy; Complications

Start date: 2022-05-20
Primary completion: 2023-12-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.